End Cash: The amount of cash held by the company for the given period.
BioMarin Pharmaceutical Inc. (BMRN) had End Cash of $1.31B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$874.56M |
|
$-46.57M |
|
$275.71M |
|
$598.86M |
|
$919.17M |
|
$-44.61M |
|
$17.46M |
|
$-27.15M |
|
$-27.15M |
|
$-46.57M |
|
$-46.57M |
|
$-46.57M |
|
$-46.57M |
|
$-44.61M |
|
$-25.28M |
|
191.79M |
|
197.39M |
|
$-0.24 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$3.95B |
|
$952.51M |
|
$3.64B |
|
$7.59B |
|
$759.03M |
|
$597.18M |
|
$747.99M |
|
$1.51B |
|
$6.09B |
|
$5.68B |
|
$6.09B |
|
192.30M |
|
| Cash Flow Statement Financials | |
$827.99M |
|
$-414.24M |
|
$-42.39M |
|
$942.84M |
|
|
End Cash |
$1.31B |
$368.84M |
|
$181.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.21 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
68.47% |
|
-5.10% |
|
-5.10% |
|
-- |
|
-3.10% |
|
-5.33% |
|
$724.96M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.21 |
|
0.96 |
|
93.46 |
|
-0.77% |
|
-0.82% |
|
-0.61% |
|
-0.70% |
|
$31.65 |
|
$3.67 |
|
$4.19 |
|